Finland· FI-REL-REL39832

Kaletra

A lopinavir and ritonavir product containing lopinavir + ritonavir, registered in Finland by Orifarm Oy. The same ATC class is registered in 15 of our 19 countries.

ATC J05AR10

Checked against Fimea (Finland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lopinavir + ritonavirAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lopinavir and ritonavir is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AR10 (lopinavir and ritonavir), each read from that country’s own register.

This record: Finland, from Fimea (Finland)
10 of them publish a price we can compare per daily dose

Search lopinavir and ritonavir products by name

Lopinavir and ritonavir · ATC J05AR10

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lopinavir and ritonavir costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $17.81 in Switzerland to $763.00 in France — a ×43 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Lopinavir and ritonavir · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

FR France$763.00
CH Switzerland$17.81

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)

Active substance: Lopinavir + Ritonavir
Manufacturer: Orifarm Oy
Country: Finland (FI)
ATC code: J05AR10
ATC class: Lopinavir and ritonavir
Defined daily dose: 0.8 g, O
Reimbursed: Not published by this register
Source register: Fimea (Finland)
Last checked: September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

136 interactions on record for lopinavir and ritonavir.

Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lopinavir and ritonavir against other medicines How interaction checks work

Lopinavir and ritonavir · interactions on record

136 records

17 severe
71 moderate
7 minor

Most severe, free to view

PapaverineA03AD01severe
DolasetronA04AA04severe
PapaverinC04AX38severe
RosuvastatinC10AA07severe

41 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lopinavir and ritonavir in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lopinavir and ritonavir products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

Estonia · Lopinavir/Ritonavir Ranbaxy, Lopinavir/Ritonavir Sun
Spain · Lopinavir / Ritonavir Accord
France · Lopinavir/Ritonavir Dextreg
United Kingdom (Northern Ireland) · Kaletra, Lopinavir / Ritonavir Accord
Iceland · Kaletra, Lopinavir/Ritonavir Mylan
Liechtenstein · Kaletra, Lopinavir/Ritonavir Viatris
Lithuania · Lopinavir / Ritonavir Sun, Lopinavir /Ritonavir Ranbaxy
Latvia · Lopinavir/ Ritonavir Ranbaxy, Lopinavir/ Ritonavir Sun
Netherlands · Lopinavir/Ritonavir Accord
Norway · Kaletra, Lopinavir/Ritonavir Viatris
Portugal · Lopinavir + Ritonavir Farmoz
Slovenia · Lopinavir/Ritonavir Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b4517612-936a-4413-a641-7df5574a15cc
GET /v1/drugs/b4517612-936a-4413-a641-7df5574a15cc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.8",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "200 mg / 50 mg",
  "atc_label": "lopinaviiri ja ritonaviiri",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/01/172/004,008",
  "fimea_rel_id": "REL39832",
  "authorised_at": "2011-04-13"
}

API reference MCP server Plans

See everything about lopinavir and ritonavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console